Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SIRT2 inhibitors(sirtuin 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | JP | - | |
Neoplasms | Preclinical | JP | - | |
Neoplasms | Preclinical | FI | - | |
Neoplasms | Preclinical | JP | - | |
Neurodegenerative Diseases | Preclinical | JP | - | |
Neurodegenerative Diseases | Preclinical | FI | - | |
Neurodegenerative Diseases | Preclinical | JP | - | |
Neurodegenerative Diseases | Preclinical | JP | - |